Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.
about
Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute NeuropathologiesSystems parasitology: effects of Fasciola hepatica on the neurochemical profile in the rat brain.Genistein modulation of streptozotocin diabetes in male B6C3F1 mice can be induced by dietDJ-1 Protects Pancreatic Beta Cells from Cytokine- and Streptozotocin-Mediated Cell Death.Adenosine receptor activation ameliorates type 1 diabetes.The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias.Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo.The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetesThe novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injuryResetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors.Comparing systemic metabolic responses in mice to single or dual infection with Plasmodium berghei and Heligmosomoides bakeri.Streptozotocin-induced diabetic models in mice and rats.Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.Enhancement of inosine-mediated A2AR signaling through positive allosteric modulation.Streptozotocin-Induced Diabetic Models in Mice and Rats.
P2860
Q28072353-1269C3CB-FF2A-46E1-88E1-6F4EBF29AD5BQ34078891-D23BC8EF-F4DB-4D48-9336-B0D296AD6366Q34619801-926340D8-7905-42F0-B07D-0CBFDA201DDCQ35793569-1CC21254-089E-4F01-84D9-25E4B8D4ACEAQ36427003-7FE54783-F61E-46C4-914B-B32F735A62A6Q36784329-9871FD80-2EC3-482F-8A21-BD90CDA32AE0Q36977456-87CCDAF8-B2FB-48A1-AC9A-A2DA010CC001Q37160327-6066F745-BD5A-47A9-AF20-49720D62BEC9Q37373697-37CC5B85-F199-4515-8C6D-CE1E77CA5006Q37549749-BEFC5A41-3F27-4AB7-8BB0-BF8075D1D273Q39534286-CE53F30B-772F-4C4B-8768-3E3DD2BEC92AQ42721766-1D8CAFAF-40C7-4573-B1AE-4C37FA107E5AQ42847715-9A953597-FD69-4786-ACD2-3346A61444F0Q50064386-2A40E6E9-5CE8-4618-8861-15D1ABE6DFF0Q53359503-63966C2F-7E68-4F65-83A3-409A9A8EB0C8
P2860
Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inosine protects against the d ...... use models of type 1 diabetes.
@ast
Inosine protects against the d ...... use models of type 1 diabetes.
@en
Inosine protects against the d ...... use models of type 1 diabetes.
@nl
type
label
Inosine protects against the d ...... use models of type 1 diabetes.
@ast
Inosine protects against the d ...... use models of type 1 diabetes.
@en
Inosine protects against the d ...... use models of type 1 diabetes.
@nl
prefLabel
Inosine protects against the d ...... use models of type 1 diabetes.
@ast
Inosine protects against the d ...... use models of type 1 diabetes.
@en
Inosine protects against the d ...... use models of type 1 diabetes.
@nl
P2093
P2860
P1433
P1476
Inosine protects against the d ...... use models of type 1 diabetes.
@en
P2093
Alex Rabinovitch
Andrew Salzman
Csaba Szabó
Gary Southan
György Haskó
Jon G Mabley
Pál Pacher
Robert Power
Wilma Suarez-Pinzon
P2860
P2888
P304
P356
10.2119/2003-00016.MABLEY
P407
P577
2003-03-01T00:00:00Z
P6179
1068964884